IASLC

Lung Cancer Considered

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informat...

Vizitează neapărat site-ul podcastului și susține-i creatorul: www.iaslc.org

Autor

IASLC

Categorie

Science

Site-ul podcastului

www.iaslc.org

Cel mai nou episod

17 nov. 2026

Unde asculți?

Podcasturi în aplicație Replaio Radio În curând

Podcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor

Descarcă din Google Play Instalează gratuit Android 10 mil.+ descărcări · nota 4,7+ iOS în curând

Episoade

LCC in Arabic: WCLC 2025 Highlights 03.10.2025

The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages. In this episode, host Dr. Nagla Abdel Karim moderates a discussion in Arabic about highlights from the conference with Dr. Riad Abdeljalil,...

Lung Cancer Considered: Targeting EGFR NSCLC 03.10.2025

Lung Cancer Considered: Targeting EGFR NSCLC by IASLC

Lung Cancer Considered in Dutch: Targeting EGFR NSCLC 03.10.2025

As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Lizza Hendriks moderates a discussion in Dutch with Dr. Marthe Paats and Dr. Gerrina Ruiter on the treatment of EGFR non-small cell lung cancer.

Lung Cancer Considered in Japanese---2025 WCLC Highlights 02.10.2025

The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages. In this episode, host Dr. Misako Nagasaka moderates a discussion in Japanese about highlights from the conference with Dr. Hidehito Horinou...

LCC in Korean: WCLC 2025 Highlights 30.09.2025

The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages. In this episode, host Dr. Chul Kim moderates a discussion in Korean about highlights from the conference with Dr. Jeongmin Seo and Dr. Min...

IASLC Lung Cancer Considered: FDA Approval: Subcutaneous Immunotherapy 26.09.2025

This episode of Lung Cancer Considered reviews new and upcoming approvals for subcutaneous immune checkpoint inhibitors. Join host Dr. Narjust Florez and guests, Dr. Cheryl Ho and Dr. Maria Velez Velez, for a discussion of the formulation and its place in the management of patients with lung cancer. Guests: Cheryl Ho, MD, FRCPC Thoracic Oncologist, BC Cancer Clinical Associate Professor and Fellow...

LCC in Mandarin: WCLC 2025 Highlights with Experts from Taiwan 18.09.2025

The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages. In this episode, guest host Dr. Kuan Yu Chen moderates a discussion in Mandarin with Dr. Bin-Chi Liao and Dr. Jeng-Sen Tseng, leading lung...

LCC in Portuguese: WCLC 2025 Highlights 16.09.2025

The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages. In this episode, host Dr. Clarissa Mathias moderates a discussion in Portuguese about highlights from the conference with Dr. Clarissa Bald...

LCC in Spanish: WCLC 2025 Through a Junior Faculty Lens 11.09.2025

In this episode, recorded live in Spanish at WCLC 2025, Dr. Diego Carrillo reflects on his experiences as a junior faculty member at WCLC 2025. In conversation with host Dr. Narjust Florez, they discuss conference activities, research highlights, and how WCLC helps junior faculty build their networks and shape the future of lung cancer care and research.

LCC in Hebrew: WCLC 2025 Highlights 10.09.2025

The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages. In this episode, host Dr. Alona Zer moderates a discussion in Hebrew about highlights from the conference with Dr. Haitam Nasrallah, Dr. Ja...

Live From WCLC 2025: Tuesday Highlights & Meeting Summary 09.09.2025

In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss highlights from the conference. Dr. Susan Scott discusses EGFR mutant NSCLC and results from PALOMA-2 and subcutaneous amivantamab. Dr. Wenfeng Fang discusses Iza-Bren (BL-D01D1), a first-in-class EGFR x HER-3 biospecific ADC linked to a novel topoisomerase I inhibitor payload, with pr...

LCC in Spanish: WCLC 2025 Highlights 09.09.2025

The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages. In this episode, host Dr. Narjust Florez moderates a discussion in Spanish about highlights from the conference with Dr. Laura Mezquita and...

Live From WCLC 2025: Monday Highlights 08.09.2025

In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference. Dr. Tina Cascone discusses results from the NADIM ADJUVANT Phase III trial. Dr. Jacie Jiaqi Law shares survival outcomes of VATS compared to open lobectomy, and Dr. Corinne Faivre-Finn and Dr. Shankar Siva summarize results from the EA5181 trial of...

LCC in Mandarin: WCLC 2025 Highlights 08.09.2025

The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages. In this episode, host Dr. Chunxia Su moderates a discussion in Mandarin Chinese about highlights from the conference with Dr. Yang Xia and...

Live From WCLC 2025: Sunday Highlights 07.09.2025

In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference. Dr. David Planchard discusses the data that we all were waiting for the FLAURA-2 overall survival. Dr. Alexander Drilon shares results from the ARROS-1 study including efficacy results and safety data for zidesamtinib, a new ROS1 inhibitor that cou...

"I'm in Barcelona, Now What?" — Tips for First-Time WCLC Attendees 06.09.2025

In this episode of Lung Cancer Considered, Dr. Narjust Florez and Dr. Stephen Liu share tips for first-time attendees of the World Conference on Lung Cancer (WCLC). Recorded live at WCLC 2025, hear their 10 key recommendations to make the most of your experience, including advice on how to sneak self-care into your busy conference schedule.

LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC 29.08.2025

LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC by IASLC

IASLC - ALK Positive Summit 26.08.2025

IASLC - ALK Positive Summit by IASLC

LCC in Greek: Virtual Tumor Board - ALK NSCLC 22.08.2025

LCC in Greek: Virtual Tumor Board - ALK NSCLC by IASLC

Lung Cancer Considered--STK11 and KEAP1 as resistance mechanisms to immunotherapy 19.08.2025

Lung Cancer Considered--STK11 and KEAP1 as resistance mechanisms to immunotherapy by IASLC

LCC in Cantonese: Novel Treatment for Advanced EGFR Mutant Lung Cancer 15.08.2025

LCC in Cantonese: Novel Treatment for Advanced EGFR Mutant Lung Cancer by IASLC

FDA Approval: Zongertinib for HER2 Mutant NSCLC 12.08.2025

FDA Approval: Zongertinib for HER2 Mutant NSCLC by IASLC

LCC in Arabic: Arab Women's Voices in Thoracic Oncology 08.08.2025

As part of IASLC’s ongoing series of podcasts in world languages, Dr. Nagla Abdel Karim moderates a discussion in Arabic with Dr. Asrar AlAhmadi and Dr. Maya Khalil. The group discusses the journey and career development of Arabic women in the field of thoracic oncology.

Artificial Intelligence (AI) and Lung Cancer Treatment Decisions 05.08.2025

Artificial Intelligence (AI) and Lung Cancer Treatment Decisions by IASLC

Artificial Intelligence (AI) and Lung Cancer Treatment Decisions 05.08.2025

Artificial Intelligence (AI) and Lung Cancer Treatment Decisions by IASLC

Ascultă podcastul Lung Cancer Considered în Replaio

Radio și podcasturi într-o singură aplicație - gratuit și fără înregistrare. Instaleaz-o azi și nu rata lansarea

Descarcă din Google Play

Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice